Aiming Pang

1.2k total citations
103 papers, 573 citations indexed

About

Aiming Pang is a scholar working on Hematology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Aiming Pang has authored 103 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Hematology, 22 papers in Immunology and 20 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Aiming Pang's work include Hematopoietic Stem Cell Transplantation (50 papers), Acute Myeloid Leukemia Research (36 papers) and Acute Lymphoblastic Leukemia research (20 papers). Aiming Pang is often cited by papers focused on Hematopoietic Stem Cell Transplantation (50 papers), Acute Myeloid Leukemia Research (36 papers) and Acute Lymphoblastic Leukemia research (20 papers). Aiming Pang collaborates with scholars based in China, United States and Australia. Aiming Pang's co-authors include Erlie Jiang, Sizhou Feng, Weihua Zhai, Qiaoling Ma, Yi He, Donglin Yang, Jialin Wei, Rongli Zhang, Mingzhe Han and Yujie Cui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Aiming Pang

83 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aiming Pang China 13 259 118 109 85 79 103 573
Rongfu Zhou China 14 258 1.0× 41 0.3× 104 1.0× 75 0.9× 142 1.8× 63 545
Olga Aleinikova Belarus 11 220 0.8× 80 0.7× 110 1.0× 44 0.5× 86 1.1× 50 517
Tatsuyuki Hayashi Japan 10 196 0.8× 54 0.5× 91 0.8× 53 0.6× 155 2.0× 16 516
M. Sivakumaran United Kingdom 17 146 0.6× 205 1.7× 146 1.3× 138 1.6× 73 0.9× 50 694
Giuseppe Palumbo Italy 17 314 1.2× 205 1.7× 223 2.0× 154 1.8× 135 1.7× 59 820
Michael J. Krisinger Canada 9 163 0.6× 210 1.8× 90 0.8× 83 1.0× 31 0.4× 10 488
M. Nishida Japan 8 136 0.5× 141 1.2× 101 0.9× 41 0.5× 65 0.8× 26 585
Tomoyuki Sakai Japan 15 140 0.5× 97 0.8× 171 1.6× 56 0.7× 251 3.2× 54 743
Junjie Fang China 8 81 0.3× 104 0.9× 174 1.6× 42 0.5× 90 1.1× 16 468
Cindy Huynh United States 9 56 0.2× 69 0.6× 85 0.8× 84 1.0× 155 2.0× 23 494

Countries citing papers authored by Aiming Pang

Since Specialization
Citations

This map shows the geographic impact of Aiming Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiming Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiming Pang more than expected).

Fields of papers citing papers by Aiming Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiming Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiming Pang. The network helps show where Aiming Pang may publish in the future.

Co-authorship network of co-authors of Aiming Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Aiming Pang. A scholar is included among the top collaborators of Aiming Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiming Pang. Aiming Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lin, Qingsong, et al.. (2025). Predictors of mortality and progression from colonization to Stenotrophomonas maltophilia bloodstream infection in hematologic disorders: a single-center retrospective study. European Journal of Clinical Microbiology & Infectious Diseases. 44(11). 2609–2621.
4.
Sun, Huimin, Xueying Zhao, Aiming Pang, et al.. (2024). Monocytes as an early risk factor for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Frontiers in Immunology. 15. 1433091–1433091. 1 indexed citations
5.
Wang, Jiali, Xinhui Zheng, Qi Sun, et al.. (2024). Impact of bone marrow fibrosis on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplantation. 59(12). 1654–1666. 2 indexed citations
6.
Wang, Mingyang, Yawei Zheng, Xiaoyu Zhang, et al.. (2024). WT1 gene mutations impact post-transplant relapse in myelodysplastic syndrome with excess blasts 2 patients. Annals of Hematology. 103(8). 2827–2836. 1 indexed citations
8.
He, Yi, Donglin Yang, Qiaoling Ma, et al.. (2023). Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy:a Single Center Analysis in the Real World. Blood. 142(Supplement 1). 5900–5900.
9.
He, Yi, Donglin Yang, Qiaoling Ma, et al.. (2023). Outcomes of allogeneic or autologous stem cell transplantation followed by maintenance chemotherapy in adult patient with B‐ALL in CR1 with no detectable minimal residual disease. British Journal of Haematology. 202(2). 369–378. 3 indexed citations
10.
11.
Liu, Li, Xiaolei Pei, Yi He, et al.. (2023). Intravenous-oral itraconazole versus oral posaconazole in preventing invasive fungal diseases for acute leukemia patients. SHILAP Revista de lepidopterología. 5(2). 106–110.
12.
Zhai, Weihua, Jialin Wei, Qiaoling Ma, et al.. (2023). Venetoclax Plus Azacitidine Versus Azacitidine Alone As Post-Transplant Maintenance Treatment in High-Risk AML and MDS. Blood. 142(Supplement 1). 4952–4952. 1 indexed citations
13.
Chen, Xin, Rongli Zhang, Weihua Zhai, et al.. (2023). Application prospect of low-dose porcine anti-thymocyte globulin in HLA-matched sibling donor transplantation. Hematology. 28(1). 2212943–2212943. 3 indexed citations
14.
Liu, Xin, Weihua Zhai, Fengjiao Wang, et al.. (2023). Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation. European Journal Of Haematology. 110(5). 527–533. 7 indexed citations
15.
Zhai, Weihua, Aiming Pang, Donglin Yang, et al.. (2023). Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia. Blood. 142(Supplement 1). 5893–5893.
17.
Teng, Yan, Fabien Loison, Aiming Pang, et al.. (2021). Targeting multiple cell death pathways extends the shelf life and preserves the function of human and mouse neutrophils for transfusion. Science Translational Medicine. 13(604). 18 indexed citations
18.
Pang, Aiming, Ni Cheng, Yujie Cui, et al.. (2020). High-loading Gα 13 -binding EXE peptide nanoparticles prevent thrombosis and protect mice from cardiac ischemia/reperfusion injury. Science Translational Medicine. 12(552). 32 indexed citations
19.
Ding, Zhe, Mingzhe Han, Qiaoling Ma, et al.. (2015). Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease. Chinese Medical Journal. 128(15). 2065–2071. 7 indexed citations
20.
Ma, Fengxia, Shaoguang Yang, Fang Chen, et al.. (2013). Expression and role of Toll-like receptors on human umbilical cord mesenchymal stromal cells. Cytotherapy. 15(4). 423–433. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026